To Evaluate the Safety and Metabolic Profile of Vyvanse for the Treatment of ADHD in Euthymic Adults With Bipolar I/II Disorder

NCT01263548 · clinicaltrials.gov ↗

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Attention Deficit/Hyperactivity Disorder
Bipolar Disorder

Interventions

DRUG: lisdexamfetamine dimesylate

Sponsor

University Health Network, Toronto

Collaborators

[object Object]